Cardiac Science, a provider of cardiac diagnosis, resuscitation, rehabilitation and informatics products, plans to reduce its current staff by approximately 12 percent and cut other expenses.
“In 2009 we see the potential for slower demand due to the weakening world economy,” said John Hinson, CEO and president. “Consequently, we will proactively reduce our cost structure, which will position the company to operate profitably under a broad range of economic scenarios and to take advantage of strategic opportunities that may arise.”
As part of the plan, the Bothell, Wash.-based Cardiac Science said that certain functions, including marketing and product development, will be reorganized to increase efficiency and support future growth. The company expects to incur pre-tax charges of between $1 million and $1.2 million in the first quarter of this year to reflect expenses associated with the restructuring.